查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1678723

脑肿瘤诊断与治疗市场规模、份额、趋势分析报告：按类型、产品、诊断、治疗、最终用途、地区和细分市场预测，2025-2030 年

Brain Tumor Diagnosis And Therapeutics Market Size, Share & Trends Analysis Report By Type (Primary, Secondary), By Product, By Diagnosis (MRI, CT, PET-CT), By Therapeutics, By End Use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

脑肿瘤诊断和治疗市场的成长和趋势

预计到 2030 年全球脑瘤诊断和治疗市场规模将达到 49.4 亿美元，2025 年至 2030 年的复合年增长率为 7.3%。

由于各种脑瘤（尤其是胶质母细胞瘤）的发生率不断增加，以及老年人口的增加，预计该市场在预测期内将出现良好的增长。

医疗保健领域官民合作关係(PPP) 的兴起正在实现诊断成像和放射学服务的现代化，支持该行业的扩张。钠磁振造影 (23Na MRI)、正子断层扫描 (PET) 和化学交换饱和转移 (CEST) 等新技术正在多中心临床测试环境中用于检测脑肿瘤反应。此外，这些技术可用于定量成像肿瘤对治疗的反应，从而促进其在治疗期间的使用。

这些技术有可能将 MRI 扩展到解剖成像之外，提供有关生理和细胞代谢的信息，从而提高诊断效率。因此，预计市场在预测期内将见证生产成长。

此外，正在进行的分子诊断研究旨在从细胞层面了解恶性肿瘤的细胞生物学并识别与恶性肿瘤相关的基因突变，预计将对该产业的发展做出重大贡献。

然而，脑瘤诊断的费用很高，从450美元到12,200美元不等，可能会阻碍全球脑瘤诊断市场的成长。

脑肿瘤诊断与治疗市场报告重点

  • 诊断成像技术的进步极大地增强了市场的能力。
  • 领先细分市场将主导市场，到 2024 年将占据 62.7% 的份额。
  • 着色剂和清漆将引领市场，到 2024 年的市占率将达到 25.7%。
  • 电脑断层扫描占据市场主导地位，2024 年的收入份额为 25.8%。
  • 2024 年，外科手术占最大份额，达 35.6%。
  • 2024 年肿瘤治疗中心占据最大的市场占有率，为 48.5%。
  • 2024年北美脑肿瘤诊断与治疗市场占据全球市场主导地位，收益占有率为41.9%。

目录

第一章调查方法与范围

第 2 章执行摘要

第 3 章脑肿瘤诊断与治疗市场变数、趋势与范围

  • 市场体系展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 商业环境分析
    • 产业分析 – 波特五力分析
    • PESTLE分析

第四章脑肿瘤诊断与治疗市场：类型业务分析

  • 2024 年及 2030 年类型市场占有率
  • 类型细分仪表板
  • 2018 年至 2030 年按类型分類的市场规模、预测与趋势分析
  • 基本的
  • 次要

第五章脑肿瘤诊断与治疗市场：产品业务分析

  • 2024 年及 2030 年产品市场占有率
  • 产品细分仪表板
  • 2018 年至 2030 年按产品分類的市场规模、预测与趋势分析
  • 染色剂和清漆
  • 虫胶
  • 漆
  • 其他的

第六章脑肿瘤诊断与治疗市场：诊断业务分析

  • 2024 年和 2030 年诊断市场占有率
  • 诊断细分仪表板
  • 市场规模、预测和趋势分析（按诊断），2018 年至 2030 年
  • MRI
  • 电脑断层扫描
  • 组织样本采集
  • 正子电脑断层扫描
  • 脑动脉造影
  • 腰椎穿刺
  • 分子检测
  • 脑电图
  • 其他的

第七章脑肿瘤诊断与治疗市场：治疗业务分析

  • 2024 年和 2030 年治疗市场占有率
  • 治疗细分仪表板
  • 2018 年至 2030 年按治疗类型分類的市场规模、预测和趋势分析
  • 外科手术
  • 放射治疗
  • 化疗
  • 免疫疗法
  • 标靶治疗
  • 其他的

8. 脑肿瘤诊断与治疗市场-最终用途业务分析

  • 2024 年及 2030 年终端用途市场占有率
  • 最终用途细分仪表板
  • 2018 年至 2030 年按最终用途分類的市场规模、预测和趋势分析
  • 医院
  • 肿瘤中心
  • 其他的

第九章脑肿瘤诊断和治疗市场：按地区估计和趋势分析

  • 2024 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 市场规模、预测趋势分析，2018-2030
  • 北美洲
    • 按国家/地区，2018 年至 2030 年
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 按国家/地区，2018 年至 2030 年
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 丹麦
    • 瑞典
  • 亚太地区
    • 按国家/地区，2018 年至 2030 年
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 按国家/地区，2018 年至 2030 年
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 按国家/地区，2018 年至 2030 年
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第十章 竞争格局

  • 参与者概述
  • 企业市场分析
  • 公司分类
  • 战略地图
  • 公司简介/上市公司
    • Amgen Inc.
    • AstraZeneca
    • Bayer Corporation
    • GE HealthCare
    • F. Hoffmann-La Roche Ltd
    • Eisai Co., Ltd.
    • Bristol-Myers Squibb Company
    • Pfizer Inc.
    • Shimadzu Corporation
    • Siemens Healthineers AG
Product Code: GVR-1-68038-349-2

Brain Tumor Diagnosis And Therapeutics Market Growth & Trends:

The global brain tumor diagnosis and therapeutics market size is expected to reach USD 4.94 billion in 2030 and is projected to grow at a CAGR of 7.3% from 2025 to 2030. The market is expected to pose lucrative growth over the forecast period, owing to the increasing incidence of various brain cancers, particularly glioblastoma, coupled with the rising geriatric population.

Increasing Public-Private Partnerships (PPPs) in the health sector, which are modernizing diagnostic imaging and radiology services, are supporting the expansion of this industry. Emerging technologies like Sodium Magnetic Resonance Imaging(23Na MRI), Positron Emission Tomography (PET), and Chemical Exchange Saturation Transfer (CEST) are used to detect the response of brain tumors in multicenter clinical trial settings. In addition, these technologies are helpful in quantitatively imaging tumor response to therapies, thereby promoting their use during treatment.

These technologies have the potential to extend MRI beyond anatomical imaging by providing information on physiology and cellular metabolism, thereby increasing the efficiency of diagnosis. Hence, the market is expected to witness productive growth over the forecast period.

Moreover, ongoing research in molecular diagnostics to understand cell biology at the cellular level of malignancy and identification of gene mutations associated with malignancy is anticipated to significantly contribute toward the growth of the industry.

On the other hand, the high cost of diagnosing brain tumors, which ranges from USD 450 to 12,200, is likely to hinder the growth of the global brain tumor diagnosis market.

Brain Tumor Diagnosis And Therapeutics Market Report Highlights:

  • Advancements in diagnostic imaging technologies have significantly enhanced the capabilities within the market
  • The primary segment dominated the market and accounted for a share of 62.7% in 2024
  • Stains & varnishes led the market and accounted for a share of 25.7% in 2024
  • CT scan dominated the market with a revenue share of 25.8% in 2024
  • Surgery held the largest market share of 35.6% in 2024
  • Oncology treatment centers held the largest market share of 48.5% in 2024
  • North America brain tumor diagnosis and therapeutics market dominated the global market with a revenue share of 41.9% in 2024

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Product
    • 1.2.3. Diagnosis
    • 1.2.4. Therapeutics
    • 1.2.5. End Use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Brain Tumor Diagnosis and Therapeutics Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Brain Tumor Diagnosis and Therapeutics Market: Type Business Analysis

  • 4.1. Type Market Share, 2024 & 2030
  • 4.2. Type Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. Primary
    • 4.4.1. Primary Market, 2018 - 2030 (USD Million)
    • 4.4.2. Meningioma
      • 4.4.2.1. Meningioma Market, 2018 - 2030 (USD Million)
    • 4.4.3. Gliomas
      • 4.4.3.1. Gliomas Market, 2018 - 2030 (USD Million)
    • 4.4.4. Astrocytomas
      • 4.4.4.1. Astrocytomas Market, 2018 - 2030 (USD Million)
    • 4.4.5. Pituitary Tumors
      • 4.4.5.1. Pituitary Tumors Market, 2018 - 2030 (USD Million)
    • 4.4.6. Others
      • 4.4.6.1. Others Market, 2018 - 2030 (USD Million)
  • 4.5. Secondary
    • 4.5.1. Secondary Market, 2018 - 2030 (USD Million)

Chapter 5. Brain Tumor Diagnosis and Therapeutics Market: Product Business Analysis

  • 5.1. Product Market Share, 2024 & 2030
  • 5.2. Product Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 5.4. Stains & Varnishes
    • 5.4.1. Stains & Varnishes Market, 2018 - 2030 (USD Million)
  • 5.5. Shellacs
    • 5.5.1. Shellacs Market, 2018 - 2030 (USD Million)
  • 5.6. Lacquers
    • 5.6.1. Lacquers Market, 2018 - 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Brain Tumor Diagnosis and Therapeutics Market: Diagnosis Business Analysis

  • 6.1. Diagnosis Market Share, 2024 & 2030
  • 6.2. Diagnosis Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by Diagnosis, 2018 to 2030 (USD Million)
  • 6.4. MRI
    • 6.4.1. MRI Market, 2018 - 2030 (USD Million)
  • 6.5. CT Scan
    • 6.5.1. CT Scan Market, 2018 - 2030 (USD Million)
  • 6.6. Tissue Sampling
    • 6.6.1. Tissue Sampling Market, 2018 - 2030 (USD Million)
  • 6.7. PET-CT scan
    • 6.7.1. PET-CT scan Market, 2018 - 2030 (USD Million)
  • 6.8. Cerebral Arteriogram
    • 6.8.1. Cerebral Arteriogram Market, 2018 - 2030 (USD Million)
  • 6.9. Lumbar Puncture
    • 6.9.1. Lumbar Puncture Market, 2018 - 2030 (USD Million)
  • 6.10. Molecular Testing
    • 6.10.1. Molecular Testing Market, 2018 - 2030 (USD Million)
  • 6.11. EEG
    • 6.11.1. EEG Market, 2018 - 2030 (USD Million)
  • 6.12. Others
    • 6.12.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. Brain Tumor Diagnosis and Therapeutics Market: Therapeutics Business Analysis

  • 7.1. Therapeutics Market Share, 2024 & 2030
  • 7.2. Therapeutics Segment Dashboard
  • 7.3. Market Size & Forecasts and Trend Analysis, by Therapeutics, 2018 to 2030 (USD Million)
  • 7.4. Surgery
    • 7.4.1. Surgery Market, 2018 - 2030 (USD Million)
  • 7.5. Radiation Therapy
    • 7.5.1. Radiation Therapy Market, 2018 - 2030 (USD Million)
  • 7.6. Chemotherapy
    • 7.6.1. Chemotherapy Market, 2018 - 2030 (USD Million)
  • 7.7. Immunotherapy
    • 7.7.1. Immunotherapy Market, 2018 - 2030 (USD Million)
  • 7.8. Targeted Therapy
    • 7.8.1. Targeted Therapy Market, 2018 - 2030 (USD Million)
  • 7.9. Others
    • 7.9.1. Others Market, 2018 - 2030 (USD Million)

Chapter 8. Brain Tumor Diagnosis and Therapeutics Market: End Use Business Analysis

  • 8.1. End Use Market Share, 2024 & 2030
  • 8.2. End Use Segment Dashboard
  • 8.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 8.4. Hospitals
    • 8.4.1. Hospitals Market, 2018 - 2030 (USD Million)
  • 8.5. Oncology Treatment Centers
    • 8.5.1. Oncology Treatment Centers Market, 2018 - 2030 (USD Million)
  • 8.6. Others
    • 8.6.1. Others Market, 2018 - 2030 (USD Million)

Chapter 9. Brain Tumor Diagnosis and Therapeutics Market: Regional Estimates & Trend Analysis

  • 9.1. Regional Market Share Analysis, 2024 & 2030
  • 9.2. Regional Market Dashboard
  • 9.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 9.4. North America
    • 9.4.1. North America Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 9.4.2. U.S.
      • 9.4.2.1. Key Country Dynamics
      • 9.4.2.2. Regulatory Framework
      • 9.4.2.3. Competitive Insights
      • 9.4.2.4. U.S. Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.4.3. Canada
      • 9.4.3.1. Key Country Dynamics
      • 9.4.3.2. Regulatory Framework
      • 9.4.3.3. Competitive Insights
      • 9.4.3.4. Canada Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.4.4. Mexico
      • 9.4.4.1. Key Country Dynamics
      • 9.4.4.2. Regulatory Framework
      • 9.4.4.3. Competitive Insights
      • 9.4.4.4. Mexico Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.5. Europe
    • 9.5.1. Europe Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 9.5.2. UK
      • 9.5.2.1. Key Country Dynamics
      • 9.5.2.2. Regulatory Framework
      • 9.5.2.3. Competitive Insights
      • 9.5.2.4. UK Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.5.3. Germany
      • 9.5.3.1. Key Country Dynamics
      • 9.5.3.2. Regulatory Framework
      • 9.5.3.3. Competitive Insights
      • 9.5.3.4. Germany Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.5.4. France
      • 9.5.4.1. Key Country Dynamics
      • 9.5.4.2. Regulatory Framework
      • 9.5.4.3. Competitive Insights
      • 9.5.4.4. France Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.5.5. Italy
      • 9.5.5.1. Key Country Dynamics
      • 9.5.5.2. Regulatory Framework
      • 9.5.5.3. Competitive Insights
      • 9.5.5.4. Italy Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.5.6. Spain
      • 9.5.6.1. Key Country Dynamics
      • 9.5.6.2. Regulatory Framework
      • 9.5.6.3. Competitive Insights
      • 9.5.6.4. Spain Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.5.7. Norway
      • 9.5.7.1. Key Country Dynamics
      • 9.5.7.2. Regulatory Framework
      • 9.5.7.3. Competitive Insights
      • 9.5.7.4. Norway Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.5.8. Denmark
      • 9.5.8.1. Key Country Dynamics
      • 9.5.8.2. Regulatory Framework
      • 9.5.8.3. Competitive Insights
      • 9.5.8.4. Denmark Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.5.9. Sweden
      • 9.5.9.1. Key Country Dynamics
      • 9.5.9.2. Regulatory Framework
      • 9.5.9.3. Competitive Insights
      • 9.5.9.4. Sweden Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.6. Asia Pacific
    • 9.6.1. Asia Pacific Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 9.6.2. Japan
      • 9.6.2.1. Key Country Dynamics
      • 9.6.2.2. Regulatory Framework
      • 9.6.2.3. Competitive Insights
      • 9.6.2.4. Japan Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.6.3. China
      • 9.6.3.1. Key Country Dynamics
      • 9.6.3.2. Regulatory Framework
      • 9.6.3.3. Competitive Insights
      • 9.6.3.4. China Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.6.4. India
      • 9.6.4.1. Key Country Dynamics
      • 9.6.4.2. Regulatory Framework
      • 9.6.4.3. Competitive Insights
      • 9.6.4.4. India Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.6.5. South Korea
      • 9.6.5.1. Key Country Dynamics
      • 9.6.5.2. Regulatory Framework
      • 9.6.5.3. Competitive Insights
      • 9.6.5.4. South Korea Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.6.6. Australia
      • 9.6.6.1. Key Country Dynamics
      • 9.6.6.2. Regulatory Framework
      • 9.6.6.3. Competitive Insights
      • 9.6.6.4. Australia Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.6.7. Thailand
      • 9.6.7.1. Key Country Dynamics
      • 9.6.7.2. Regulatory Framework
      • 9.6.7.3. Competitive Insights
      • 9.6.7.4. Thailand Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.7. Latin America
    • 9.7.1. Latin America Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 9.7.2. Brazil
      • 9.7.2.1. Key Country Dynamics
      • 9.7.2.2. Regulatory Framework
      • 9.7.2.3. Competitive Insights
      • 9.7.2.4. Brazil Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.7.3. Argentina
      • 9.7.3.1. Key Country Dynamics
      • 9.7.3.2. Regulatory Framework
      • 9.7.3.3. Competitive Insights
      • 9.7.3.4. Argentina Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.8. MEA
    • 9.8.1. MEA Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 9.8.2. South Africa
      • 9.8.2.1. Key Country Dynamics
      • 9.8.2.2. Regulatory Framework
      • 9.8.2.3. Competitive Insights
      • 9.8.2.4. South Africa Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.8.3. Saudi Arabia
      • 9.8.3.1. Key Country Dynamics
      • 9.8.3.2. Regulatory Framework
      • 9.8.3.3. Competitive Insights
      • 9.8.3.4. Saudi Arabia Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.8.4. UAE
      • 9.8.4.1. Key Country Dynamics
      • 9.8.4.2. Regulatory Framework
      • 9.8.4.3. Competitive Insights
      • 9.8.4.4. UAE Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.8.5. Kuwait
      • 9.8.5.1. Key Country Dynamics
      • 9.8.5.2. Regulatory Framework
      • 9.8.5.3. Competitive Insights
      • 9.8.5.4. Kuwait Brain Tumor Diagnosis and Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Participant Overview
  • 10.2. Company Market Position Analysis
  • 10.3. Company Categorization
  • 10.4. Strategy Mapping
  • 10.5. Company Profiles/Listing
    • 10.5.1. Amgen Inc.
      • 10.5.1.1. Overview
      • 10.5.1.2. Financial Performance
      • 10.5.1.3. Product Benchmarking
      • 10.5.1.4. Strategic Initiatives
    • 10.5.2. AstraZeneca
      • 10.5.2.1. Overview
      • 10.5.2.2. Financial Performance
      • 10.5.2.3. Product Benchmarking
      • 10.5.2.4. Strategic Initiatives
    • 10.5.3. Bayer Corporation
      • 10.5.3.1. Overview
      • 10.5.3.2. Financial Performance
      • 10.5.3.3. Product Benchmarking
      • 10.5.3.4. Strategic Initiatives
    • 10.5.4. GE HealthCare
      • 10.5.4.1. Overview
      • 10.5.4.2. Financial Performance
      • 10.5.4.3. Product Benchmarking
      • 10.5.4.4. Strategic Initiatives
    • 10.5.5. F. Hoffmann-La Roche Ltd
      • 10.5.5.1. Overview
      • 10.5.5.2. Financial Performance
      • 10.5.5.3. Product Benchmarking
      • 10.5.5.4. Strategic Initiatives
    • 10.5.6. Eisai Co., Ltd.
      • 10.5.6.1. Overview
      • 10.5.6.2. Financial Performance
      • 10.5.6.3. Product Benchmarking
      • 10.5.6.4. Strategic Initiatives
    • 10.5.7. Bristol-Myers Squibb Company
      • 10.5.7.1. Overview
      • 10.5.7.2. Financial Performance
      • 10.5.7.3. Product Benchmarking
      • 10.5.7.4. Strategic Initiatives
    • 10.5.8. Pfizer Inc.
      • 10.5.8.1. Overview
      • 10.5.8.2. Financial Performance
      • 10.5.8.3. Product Benchmarking
      • 10.5.8.4. Strategic Initiatives
    • 10.5.9. Shimadzu Corporation
      • 10.5.9.1. Overview
      • 10.5.9.2. Financial Performance
      • 10.5.9.3. Product Benchmarking
      • 10.5.9.4. Strategic Initiatives
    • 10.5.10. Siemens Healthineers AG
      • 10.5.10.1. Overview
      • 10.5.10.2. Financial Performance
      • 10.5.10.3. Product Benchmarking
      • 10.5.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global brain tumor diagnosis and therapeutics market, by region, 2018 - 2030 (USD Million)
  • Table 4 Global brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 5 Global brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 6 Global brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 7 Global brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
  • Table 8 Global brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)
  • Table 9 North America brain tumor diagnosis and therapeutics market, by country, 2018 - 2030 (USD Million)
  • Table 10 North America brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 11 North America brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 12 North America brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 13 North America brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
  • Table 14 North America brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)
  • Table 15 U.S. brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 16 U.S. brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 17 U.S. brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 18 U.S. brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
  • Table 19 U.S. brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)
  • Table 20 Canada brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 21 Canada brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 22 Canada brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 23 Canada brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
  • Table 24 Canada brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)
  • Table 25 Europe brain tumor diagnosis and therapeutics market, by country, 2018 - 2030 (USD Million)
  • Table 26 Mexico brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 27 Mexico brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 28 Mexico brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 29 Mexico brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
  • Table 30 Mexico brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)
  • Table 31 Europe brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 32 Europe brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 33 Europe brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 34 Europe brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
  • Table 35 Europe brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)
  • Table 36 UK brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 37 UK brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 38 UK brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 39 UK brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
  • Table 40 UK brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)
  • Table 41 Germany brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 42 Germany brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 43 Germany brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 44 Germany brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
  • Table 45 Germany brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)
  • Table 46 France brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 47 France brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 48 France brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 49 France brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
  • Table 50 France brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)
  • Table 51 Italy brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 52 Italy brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 53 Italy brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 54 Italy brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
  • Table 55 Italy brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)
  • Table 56 Spain brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 57 Spain brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 58 Spain brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 59 Spain brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
  • Table 60 Spain brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)
  • Table 61 Denmark brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 62 Denmark brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 63 Denmark brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 64 Denmark brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
  • Table 65 Denmark brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)
  • Table 66 Sweden brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 67 Sweden brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 68 Sweden brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 69 Sweden brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
  • Table 70 Sweden brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)
  • Table 71 Norway brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 72 Norway brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 73 Norway brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 74 Norway brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
  • Table 75 Norway brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)
  • Table 76 Asia Pacific brain tumor diagnosis and therapeutics market, by country, 2018 - 2030 (USD Million)
  • Table 77 Asia Pacific brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 78 Asia Pacific brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 79 Asia Pacific brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 80 Asia Pacific brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
  • Table 81 Asia Pacific brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)
  • Table 82 China brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 83 China brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 84 China brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 85 China brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
  • Table 86 China brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)
  • Table 87 Japan brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 88 Japan brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 89 Japan brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 90 Japan brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
  • Table 91 Japan brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)
  • Table 92 India brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 93 India brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 94 India brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 95 India brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
  • Table 96 India brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)
  • Table 97 Australia brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 98 Australia brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 99 Australia brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 100 Australia brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
  • Table 101 Australia brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)
  • Table 102 South Korea brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 103 South Korea brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 104 South Korea brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 105 South Korea brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
  • Table 106 South Korea brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)
  • Table 107 Thailand brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 108 Thailand brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 109 Thailand brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 110 Thailand brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
  • Table 111 Thailand brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)
  • Table 112 Latin America brain tumor diagnosis and therapeutics market, by country, 2018 - 2030 (USD Million)
  • Table 113 Latin America brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 114 Latin America brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 115 Latin America brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 116 Latin America brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
  • Table 117 Latin America brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)
  • Table 118 Brazil brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 119 Brazil brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 120 Brazil brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 121 Brazil brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
  • Table 122 Brazil brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)
  • Table 123 Argentina brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 124 Argentina brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 125 Argentina brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 126 Argentina brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
  • Table 127 Argentina brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)
  • Table 128 Middle East & Africa Brain tumor diagnosis and therapeutics market, by country, 2018 - 2030 (USD Million)
  • Table 129 Middle East & Africa brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 130 Middle East & Africa brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 131 Middle East & Africa brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 132 Middle East & Africa brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
  • Table 133 Middle East & Africa brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)
  • Table 134 South Africa brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 135 South Africa brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 136 South Africa brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 137 South Africa brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
  • Table 138 South Africa brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)
  • Table 139 Saudi Arabia brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 140 Saudi Arabia brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 141 Saudi Arabia brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 142 Saudi Arabia brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
  • Table 143 Saudi Arabia brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)
  • Table 144 UAE brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 145 UAE brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 146 UAE brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 147 UAE brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
  • Table 148 UAE brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)
  • Table 149 Kuwait brain tumor diagnosis and therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 150 Kuwait brain tumor diagnosis and therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 151 Kuwait brain tumor diagnosis and therapeutics market, by diagnosis, 2018 - 2030 (USD Million)
  • Table 152 Kuwait brain tumor diagnosis and therapeutics market, by therapeutics, 2018 - 2030 (USD Million)
  • Table 153 Kuwait brain tumor diagnosis and therapeutics market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Brain tumor diagnosis and therapeutics market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Type and product outlook (USD Million)
  • Fig. 10 Diagnosis and therapeutics outlook (USD Million)
  • Fig. 11 End use outlook (USD Million)
  • Fig. 12 Competitive landscape
  • Fig. 13 Brain tumor diagnosis and therapeutics market dynamics
  • Fig. 14 Brain tumor diagnosis and therapeutics market: Porter's five forces analysis
  • Fig. 15 Brain tumor diagnosis and therapeutics market: PESTLE analysis
  • Fig. 16 Brain tumor diagnosis and therapeutics market: Type segment dashboard
  • Fig. 17 Brain tumor diagnosis and therapeutics market: Type market share analysis, 2024 & 2030
  • Fig. 18 Primary market, 2018 - 2030 (USD Million)
  • Fig. 19 Meningioma market, 2018 - 2030 (USD Million)
  • Fig. 20 Gliomas market, 2018 - 2030 (USD Million)
  • Fig. 21 Astrocytomas market, 2018 - 2030 (USD Million)
  • Fig. 22 Pituitary tumors market, 2018 - 2030 (USD Million)
  • Fig. 23 Others market, 2018 - 2030 (USD Million)
  • Fig. 24 Secondary market, 2018 - 2030 (USD Million)
  • Fig. 25 Brain tumor diagnosis and therapeutics market: Product segment dashboard
  • Fig. 26 Brain tumor diagnosis and therapeutics market: Product market share analysis, 2024 & 2030
  • Fig. 27 Stains & varnishes market, 2018 - 2030 (USD Million)
  • Fig. 28 Shellacs market, 2018 - 2030 (USD Million)
  • Fig. 29 Lacquers market, 2018 - 2030 (USD Million)
  • Fig. 30 Others market, 2018 - 2030 (USD Million)
  • Fig. 31 Brain tumor diagnosis and therapeutics market: Diagnosis segment dashboard
  • Fig. 32 Brain tumor diagnosis and therapeutics market: Diagnosis market share analysis, 2024 & 2030
  • Fig. 33 MRI market, 2018 - 2030 (USD Million)
  • Fig. 34 CT scan market, 2018 - 2030 (USD Million)
  • Fig. 35 Tissue sampling market, 2018 - 2030 (USD Million)
  • Fig. 36 PET-CT scan market, 2018 - 2030 (USD Million)
  • Fig. 37 Cerebral arteriogram market, 2018 - 2030 (USD Million)
  • Fig. 38 Lumbar puncture market, 2018 - 2030 (USD Million)
  • Fig. 39 Molecular testing market, 2018 - 2030 (USD Million)
  • Fig. 40 EEG market, 2018 - 2030 (USD Million)
  • Fig. 41 Others market, 2018 - 2030 (USD Million)
  • Fig. 42 Brain tumor diagnosis and therapeutics market: Therapeutics segment dashboard
  • Fig. 43 Brain tumor diagnosis and therapeutics market: Therapeutics market share analysis, 2024 & 2030
  • Fig. 44 Surgery market, 2018 - 2030 (USD Million)
  • Fig. 45 Radiation therapy market, 2018 - 2030 (USD Million)
  • Fig. 46 Chemotherapy market, 2018 - 2030 (USD Million)
  • Fig. 47 Immunotherapy market, 2018 - 2030 (USD Million)
  • Fig. 48 Targeted therapy market, 2018 - 2030 (USD Million)
  • Fig. 49 Others market, 2018 - 2030 (USD Million)
  • Fig. 50 Brain tumor diagnosis and therapeutics market: End use segment dashboard
  • Fig. 51 Brain tumor diagnosis and therapeutics market: End use market share analysis, 2024 & 2030
  • Fig. 52 Hospitals market, 2018 - 2030 (USD Million)
  • Fig. 53 Oncology treatment centers market, 2018 - 2030 (USD Million)
  • Fig. 54 Others market, 2018 - 2030 (USD Million)
  • Fig. 55 Brain tumor diagnosis and therapeutics market revenue, by region
  • Fig. 56 Regional marketplace: Key takeaways
  • Fig. 57 Regional marketplace: Key takeaways
  • Fig. 58 North America brain tumor diagnosis and therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 59 U.S. country dynamics
  • Fig. 60 U.S. brain tumor diagnosis and therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 61 Canada country dynamics
  • Fig. 62 Canada brain tumor diagnosis and therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 63 Mexico country dynamics
  • Fig. 64 Mexico brain tumor diagnosis and therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 65 Europe brain tumor diagnosis and therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 66 UK country dynamics
  • Fig. 67 UK brain tumor diagnosis and therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 68 Germany country dynamics
  • Fig. 69 Germany brain tumor diagnosis and therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 70 France country dynamics
  • Fig. 71 France brain tumor diagnosis and therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 72 Italy country dynamics
  • Fig. 73 Italy brain tumor diagnosis and therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 74 Spain country dynamics
  • Fig. 75 Spain brain tumor diagnosis and therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 76 Norway country dynamics
  • Fig. 77 Norway brain tumor diagnosis and therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 78 Sweden country dynamics
  • Fig. 79 Sweden brain tumor diagnosis and therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 80 Denmark country dynamics
  • Fig. 81 Denmark brain tumor diagnosis and therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 82 Asia Pacific brain tumor diagnosis and therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 83 Japan country dynamics
  • Fig. 84 Japan brain tumor diagnosis and therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 85 China country dynamics
  • Fig. 86 China brain tumor diagnosis and therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 87 India country dynamics
  • Fig. 88 India brain tumor diagnosis and therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 89 Australia country dynamics
  • Fig. 90 Australia brain tumor diagnosis and therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 91 South Korea country dynamics
  • Fig. 92 South Korea brain tumor diagnosis and therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 93 Thailand country dynamics
  • Fig. 94 Thailand brain tumor diagnosis and therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 95 Latin America brain tumor diagnosis and therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 96 Brazil country dynamics
  • Fig. 97 Brazil brain tumor diagnosis and therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 98 Argentina country dynamics
  • Fig. 99 Argentina brain tumor diagnosis and therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 100 MEA brain tumor diagnosis and therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 101 South Africa country dynamics
  • Fig. 102 South Africa brain tumor diagnosis and therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 103 Saudi Arabia country dynamics
  • Fig. 104 Saudi Arabia brain tumor diagnosis and therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 105 UAE country dynamics
  • Fig. 106 UAE brain tumor diagnosis and therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 107 Kuwait country dynamics
  • Fig. 108 Kuwait brain tumor diagnosis and therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 109 Company categorization
  • Fig. 110 Company market position analysis
  • Fig. 111 Strategic framework